Effect of Tiotropium Bromide Combined With Odaterol on Small Airway Remodeling in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease

Unknown 72 enrolled Guangzhou Institute of Respiratory Disease Boehringer Ingelheim · collab

RandomizedParallel-groupQuadruple-blindHealth-services research

Summary

72 patients with mild to moderate chronic obstructive pulmonary disease were planned to be enrolled in this study and then treated with olodaterol combined with thiotropium bromide, and thiotropium bromide, respectively, for 52 weeks. To assess the effect of the test drug on small airway remodeling in patients.

Timeline

Start: 2021-01-25
Primary completion: 2024-09
Completion: 2025-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Olodaterol	Small molecule	5 ug	Inhaled
Background	Tiotropium	Other / unclassified	5 ug	Inhaled

Effect of Tiotropium Bromide Combined With Odaterol on Small Airway Remodeling in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease

Summary

Timeline

Drugs

Indications